Cargando…
Synthesis of Novel Suramin Analogs With Anti-Proliferative Activity via FGF1 and FGFRD2 Blockade
A promising approach in cancer therapy is the inhibition of cell proliferation using small molecules. In this study, we report the synthesis of suramin derivatives and their applications. We used NMR spectroscopy and docking simulations to confirm binding sites and three-dimensional models of the li...
Autores principales: | Parveen, Nuzhat, Lin, Yan-Liang, Chou, Ruey-Hwang, Sun, Chung-Ming, Yu, Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763243/ https://www.ncbi.nlm.nih.gov/pubmed/35047478 http://dx.doi.org/10.3389/fchem.2021.764200 |
Ejemplares similares
-
The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is through Blocking the Interaction between S100A1 and RAGE V Domain
por: Parveen, Nuzhat, et al.
Publicado: (2022) -
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
por: Danesi, R., et al.
Publicado: (1993) -
Purinergic Receptor Blockade with Suramin Increases Survival of Postnatal Neural Progenitor Cells In Vitro
por: Herrera, Alejandro, et al.
Publicado: (2021) -
1984—Discovery of the First Anti-HIV Drug, Suramin
por: De Clercq, Erik
Publicado: (2021) -
Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain
por: Khan, Md. Imran, et al.
Publicado: (2019)